HGD mediated continuous expression of phenylalanine hydroxylase (PAH) in the mouse liver, played therapeutic roles in the mouse with human phenylketonuria characteristics, by adjusting the level of phenylalanine in blood (Grisch-Chan et al., 2017). This evidence concerns the gene PAH and phenylketonuria.